• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Chair: Anuwat JIRAVARNSRIKUL (Thailand)

Date & Time: Sunday, 26 July 2026, 0715 – 0830 hrs         Venue: Level 3, Room 332

Time Abstract Title Presenter
0715 – 0719 Win Ratios in Ophthalmology- A Novel Metric to Evaluate Safety and Efficacy Outcomes in Comparative Studies Mitchell LAWLOR
Australia
0719 – 0723 Tear Film Breakup Patterns and Meibomian Gland Dysfunction in Medicated Open Angle Glaucoma: Ocular Surface Phenotyping Dinh Cang NGUYEN
Vietnam
0723 – 0727 Tubing the Trabeculectomy: A Novel Filtration Technique Arnav PANIGRAHI
India
0727 – 0731 Evaluation of Role of Oral Vitamin B12 and Folate Supplementation in Open Angle Glaucoma Surishti RAJ
India
0731 – 0735 Prospective RCT, Comparative Study of Bent Abinterno Needle Goniectomy Versus Conservative Treatment for IOP, Antiglaucoma Medication and Quality of Life Evaluation POAG Patients. Surishti RAJ
India
0735 – 0739 Contrast Sensitivity After Combined Cataract Surgery and MIGS: A Comparison of Monofocal and Enhanced Monofocal Intraocular Lenses Keigo TAKAGI
Japan
0739 – 0743 Single-Session Integrative Surgical Management of Neovascular Glaucoma with Dense Vitreous Hemorrhage Hemlata UDENIA
India
0743 – 0747 Structure-function Relationships of Circumpapillary Choroidal Thickness in Normal-tension Glaucoma With and Without High Myopia Weiwei WANG
China
0747 – 0751 A Novel Nickle-titanium Deployable Microstent Exceeds Biocompatibility and Long-term IOP Reduction to a Commercially Available Minimially Invasive Glaucoma Surgical Device Weijia ZHANG
China
0751 – 0755 Interocular Asymmetry in the Progression and Diagnosis of Normal Tension Glaucoma De-Fu CHEN
China
0755 – 0759 One-Year Clinical Outcomes of A-stream Glaucoma Shunt Implantation Jaewan CHOI
South Korea
0759 – 0803 Introducing VW-51: A New, Engineered Glaucoma Drainage Implant Michael COOTE
Australia
0803 – 0807 Structural and Functional Progression in Primary Glaucoma: Five-Year Results from a Tertiary Referral Center Fauziyyah DJAAFARA
Indonesia
0807 – 0811 An Open-label, Observational, Non-comparative, Real-World Study of Fixed Dose Combination (FDC) of Timolol 0.5%, Brimonidine 0.2% and Brinzolamide 1% Eye Drops (Trisopt) in Glaucoma Patients Alokesh GANGULY
India

Abstract submission deadline extended

Important dates
Good News! Abstract Submission Now Open Until 21 February 2026